Lexeo Therapeutics annual operating margin
2022
Lexeo Therapeutics's operating margin was −9,252.14% for fiscal 2022.
View full Lexeo Therapeutics company overview| Fiscal year | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| 2022 | 2022-12-31 | −9,252.14% | — |
| Fiscal quarter | Period ended | Operating margin | Change (percentage points) |
|---|---|---|---|
| Q3 2022 | 2022-09-30 | −3,292.28% | — |
The latest reported quarter, Q3 2022, shows −3,292.28%.
Operating margin measures the percentage of revenue left after operating costs and expenses. It shows how much operating profit a company generates from each dollar of revenue.
TickerStat calculates operating margin as SEC-reported operating income divided by SEC-reported revenue for the same fiscal period. Changes are shown in percentage points. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Lexeo Therapeutics source filings ↗